Antibiotic therapy of upper respiratory tract and ENT infections in children
https://doi.org/10.51793/OS.2024.27.9.001
Abstract
Background.In the outpatient setting, it is important for pediatricians and general practitioners to determine the indications and empirically prescribe an effective antibacterial drug in a timely manner. In the Russian Federation in recent years, clinical guidelines for various diseases have been developed and approved, defining indications for systemic antibacterial therapy, according to which amoxicillin is the starting drug for most bacterial acute respiratory infections, and inhibitor-protected aminopenicillins (amoxicillin/clavulanate) are recommended in case of ineffective therapy or drug-resistant pathogens.
Conclusion. The article presents the determining indications for the prescription of antibacterial therapy and the peculiarities of the choice of the starting antibacterial drug in such infectious-inflammatory diseases of the upper respiratory tract in children as acute tonsillitis and/or pharyngitis, acute sinusitis, acute otitis media. It is shown that the most optimal dosage form for the use of antibacterial drugs is dispersible tablets, which increases the safety of treatment and patient adherence to medical recommendations.
About the Authors
V. A. Bulgakova
Academician B. V. Petrovsky Russian Scientific Center of Surgery; N. I. Pirogov Russian National Research Medical University
Россия
Россия
Vilya A. Bulgakova, Dr. of Sci. (Med.), Head of the Department of Scientific and Information Development of the Research Institute of Pediatrics and Child Health Protection of CRC No. 2; Professor of the Department of Faculty Pediatrics, Faculty of Pediatrics
2 Abrikosovsky Lane, Moscow, 119991
1 Ostrovityanova str., Moscow, 117997
L. R. Selimzyanova
Academician B. V. Petrovsky Russian Scientific Center of Surgery; N. I. Pirogov Russian National Research Medical University; I. M. Sechenov First Moscow State Medical University
Россия
Россия
Liliia R. Selimzyanova, Cand. of Sci, (Med.), Head of the Standardization and Evidence-Based Medicine Department, of the Research Institute of Pediatrics and Child Health Protection of CRC No. 2; Associate Professor of the Department of Pediatrics and Pediatric Rheumatology at the N. F. Filatov Clinical Institute of Child Health, Federal State Autonomous Educational Institution of Higher Education
2 Abrikosovsky Lane, Moscow, 119991
1 Ostrovityanova str., Moscow, 117997
8/2 Trubetskaya str., Moscow, 119991
T. E. Privalova
Academician B. V. Petrovsky Russian Scientific Center of Surgery; N. I. Pirogov Russian National Research Medical University
Россия
Россия
Tatyana E. Privalova, Cand. of Sci, (Med.), Associate Professor of the Department of Pediatrics, Faculty of Pediatrics; Head of the Department of the Consultative and Diagnostic Center for Children of the Research Institute of Pediatrics and Child Health Protection of CRC No. 2
1 Ostrovityanova str., Moscow, 117997
2 Abrikosovsky Lane, Moscow, 119991
E. N. Kareva
N. I. Pirogov Russian National Research Medical University; I. M. Sechenov First Moscow State Medical University
Россия
Россия
Elena N. Kareva, Dr. of Sci. (Med.), Professor of the Department of Molecular Pharmacology and Radiobiology named after Academician P. V. Sergeev, Faculty of Biomedical Sciences, Federal State Autonomous Educational Institution of Higher Education; Professor of the Department of Pharmacology, Institute of Digital Biodesign and Modeling of Living Systems, Federal State Autonomous Educational Institution of Higher Education
1 Ostrovityanova str., Moscow, 117997
8/2 Trubetskaya str., Moscow, 119991
References
1. Chai G., Governale L., McMahon A. W., Trinidad J. P., Staffa J., Murphy D. Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics. 2012; 130 (1): 23-31. DOI: 10.1542/peds.2011-2879.
2. Piltcher O. B., Kosugi E. M., Sakano E., et al. How to avoid the inappropriate use of antibiotics in upper respiratory tract infections? A position statement from an expert panel. Braz J Otorhinolaryngol. 2018; 84 (3): 265-279. DOI: 10.1016/j.bjorl.2018.02.001.
3. Rachina S. A., Kozlov R. S., Tatochenko V. K., et al. Paediatricians Approach to Prescribing of Systemic Antimicrobials in Outpatient Children with Upper Respiratory Tract and ENT Infections: Data from Multicenter Survey. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2016; 18 (1): 20-32. (In Russ.)
4. Mukozheva R. A., Kulichenko T. V., Vilchanskaya T. V., et. al. Outpatient Management of Acute Respiratory Infections in Children. Pediatricheskaja farmakologija. 2021;18 (5): 359-366. (In Russ.) https://doi.org/10.15690/pf.v18i5.2298
5. Ranjbar R., Alam M. Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Evid Based Nurs. 2023 Jul 27: ebnurs-2022-103540. DOI: 10.1136/ebnurs-2022-103540.
6. Kareva E. N., Serebrova S. Yu., Lazareva N. B, et al. New antibacterial agents in the era of global resistance. Eksperimental'naja i klinicheskaja farmakologija. 2018; 81 (9): 26-32. (In Russ.) DOI: 10.30906/0869-2092-2018-81-9-26-32.
7. Lucas P. J., Cabral C., Hay A. D., Horwood J. A systematic review of parent and clinician views and perceptions that influence prescribing decisions in relation to acute childhood infections in primary care. Scand J Prim Health Care. 2015; 33 (1): 11-20. DOI: 10.3109/02813432.2015.1001942.
8. Yakovlev S. V. New Concept of Rational Use of Antibiotics in Outpatient Practice. Antibiot. Khimioter. 2019; 64 (3-4): 48-58. (In Russ.)
9. Devine P., O’Kane M., Bucholc M. Trends, Variation, and Factors Influencing Antibiotic Prescribing: A Longitudinal Study in Primary Care Using a Multilevel Modelling Approach. Antibiotics. 2021; 11: 17. DOI: 10.3390/antibiotics11010017.
10. Belov V. A., Karpova E. P., Zaplatnikov A. L., et al. Acute respiratory infections: current clinical recommendations. Focus on the issues of phytotherapy. RMZh. Medicinskoe obozrenie. 2022; 6 (7): 376-386 (in Russ.). DOI: 10.32364/2587-6821-2022-6-7-376-386.
11. Avdeev S. N., Alyeva M. Kh., Baranov A. A., et. al. Federal Clinical Guidelines on Vaccination of pneumococcal infection in children and adults. Profilakticheskaja medicina. 2023; 26 (92): 3 23. (In Russ.) https://doi.org/10.17116/profmed2023260923
12. Van den Bergh M. R., Biesbroek G., Rossen J. W., et al. Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria. PLoS One. 2012; 7 (10): e47711. DOI: 10.1371/journal.pone.0047711.
13. Bulgakova V. A., Selimzyanova L. R., Privalova T. E., Yusupova D. A. Immunisation of young children against influenza – evidence review. Lechaschi Vrach. 2022; 10 (25): 55-61. DOI: 10.51793/OS.2022.25.10.009
14. Kuzmenkov A. Yu., Trushin I. V., Avramenko A. A., et al. AMRmap: an Internetbased antibiotic resistance monitoring platform. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2017; 19 (2): 84-90.
15. Andreeva I. V., Stetsyuk O. U., Egorova O. A. Respiratory tract infections in pediatrics: difficult answers to simple questions. RMZh. Mat' i ditja. 2020; 3 (2): 105-111. DOI: 10.32364/2618-8430-2020-3-2-105-111.
16. Torumkuney D., Mayanskiy N., Edelstein M., et al. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia. J Antimicrob Chemother. 2018; 73 (suppl_5): v14-v21. DOI: 10.1093/jac/dky065.
17. Ivanchik N. V., Chagaryan A. N., Mikotina A. V., Andreev V. A. Antibiotic resistance of clinical isolates of Streptococcus pyogenes in Russia: results of multicenter epidemiological study "PEGAS 2020-2021". Collection of abstracts of XXIV Congress of Pediatricians of Russia with international participation "Actual problems of pediatrics" Moscow, March 3-5, 2023; p. 88 (available at the link: https: //pediatr-russia.ru/information/events/tezisi_2023.pdf).
18. Dronov I. A., Malakhov A. B. Antibacterial therapy in acute respiratory infections in children. Pediatria (Supplement to the journal Consilium Medicum). 2017; 4: 31-35.
19. Clinical Guidelines. Acute tonsillitis and pharyngitis (Acute tonsillopharyngitis). 2021. https://cr.minzdrav.gov.ru/recomend/306_2. (In Russ.)
20. Spinks A., Glasziou P. P., Del Mar C. B. Antibiotics for treatment of sore throat in children and adults. Cochrane Database Syst Rev. 2021; 12 (12): CD000023. DOI: 10.1002/14651858.CD000023.pub5.
21. Otto W. R., Paden W. Z., Connors M., et al. Suppurative Intracranial Complications of Pediatric Sinusitis: A Single-Center Experience. J Pediatric Infect Dis Soc. 2021; 10 (3): 309-316. DOI: 10.1093/jpids/piaa101.
22. Svistushkin V. M., Andreeva I. V., Stetsyuk O. U. Review of modern recommendations on the tactics of management of patients with acute bacterial rhinosinusitis in pediatric practice. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija 2012; 14 (3): 176-190. (In Russ.)
23. Ryazantsev S. V., Pavlova S. S., Donskaya O. S., Gorpinich V. D. Modern approaches to the treatment of acute sinusitis. Effektivnaja farmakoterapija. 2021; 17 (18): 40-45. (In Russ.)
24. Fokkens W. J., Lund V. J., Hopkins C., et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020; 58 (Suppl S29): 1-464. DOI: 10.4193/Rhin20.600.
25. Clinical Guidelines. Acute sinusitis. 2021. https: //cr.minzdrav.gov.ru/recomend/313 (In Russ.)
26. Lieberthal A. S., Carroll A. E., Chonmaitree T., et al. The diagnosis and management of acute otitis media. Pediatrics. 2013; 131 (3): e964-99. DOI: 10.1542/peds.2012-3488.
27. El Feghaly R. E., Nedved A., Katz S. E., Frost H. M. New insights into the treatment of acute otitis media. Expert Rev Anti Infect Ther. 2023; 21 (5): 523-534. DOI: 10.1080/14787210.2023.2206565.
28. Baranov A. A., Namazova-Baranova L. S., Lobzin Yu. V., et al. Modern approaches to the management of children with acute respiratory viral infection. Pediatricheskaya farmakologiya. 2023; 20 (2): 162-174. (In Russ.) DOI: 10.15690/pf.v20i2.2539.
29. Clinical guidelines. Acute middle otitis media. 2021. https://cr.minzdrav.gov.ru/recomend/314_2. (In Russ.)
30. Clinical guidelines. Pneumonia (out-of-hospital). Children. 2022. https://cr.minzdrav.gov.ru/recomend/714_1. (In Russ.)
31. Resolution of the Expert Council "Principles of rational antibiotic therapy of respiratory infections in children. Let's save antibiotics for future generations". March 31, 2018, Moscow. Pediatrics. Consilium Medicum. 2018; (3): 10-15. (In Russ.)
32. Sidorenko S. V., Dronov I. A. Amoxicillin in the treatment of acute respiratory infections in children: a dialogue between a microbiologist and a clinical pharmacologist. Rossiyskiy Vestnik Perinatologii i Pediatrii. 2020; 65 (3): 169-176. (In Russ.) https://doi.org/10.21508/1027-4065-2020-65-3-169-176
33. Swanson-Biearman B., Dean B. S., Lopez G., Krenzelok E. P. The effects of penicillin and cephalosporin ingestions in children less than six years of age. Vet Hum Toxicol. 1988; 30 (1): 66-67.
34. Pack insert for the drug Amoxicillin EXPRESS LP-005523 dated 20.05.2019 (In Russ.)
35. Abavisani M., Keikha M., Karbalaei M. First global report about the prevalence of multi-drug resistant Haemophilus influenzae: a systematic review and metaanalysis. BMC Infect Dis. 2024; 24 (1): 90. DOI: 10.1186/s12879-023-08930-5.
36. Pack insert for the drug Amoxicillin + Clavulanic acid EXPRESS LP-005622 dated 01.07.2019 (In Russ.)
37. Kozlov R. S., Sinopalnikov A. I., Zaitseva O. V., et al. Inhibitor-protected amoxicillin with increased amoxicillin content and a 14: 1 ratio of active components: place in the treatment of out-of-hospital respiratory tract and ENT infections in children. Expert Panel Resolution. Klinicheskij razbor v obshhej medicine. 2021; 2: 6-14. (In Russ.) DOI: 10.47407/kr2021.2.1.00036.
38. Orlova N. V. Antibiotic resistance and modern strategy of antibacterial therapy. Meditsinskiy Sovet. 2022; 16 (4): 89-97. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-8-89-97
39. Karpishchenko S. A., Ryabova M. A., Kolesnikova O. A., Ulupov M. Yu. M., Ulupov M. Yu. Antibacterial therapy of acute streptococcal tonsillopharyngitis: results of a randomized comparative clinical trial on the use of Amoxicillin + Clavulanic acid EXPRESS. Terapevticheskij arhiv. 2024; 96 (3): 273-279. (In Russ.)
Review
For citations:
Bulgakova V.A., Selimzyanova L.R., Privalova T.E., Kareva E.N. Antibiotic therapy of upper respiratory tract and ENT infections in children. Lechaschi Vrach. 2024;(9):9-17. (In Russ.) https://doi.org/10.51793/OS.2024.27.9.001
Views:
162
JATS XML
Email this article 
